{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:09Z","timestamp":1787032869231,"version":"build-2736575974"},"reference-count":89,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>\n                    Bladder cancer (BCa) is one of the most common malignancies of the urinary tract worldwide. Cisplatin-based combination chemotherapy remains a cornerstone of treatment for muscle-invasive and advanced disease and has substantially improved clinical outcomes, yet primary and acquired resistance frequently leads to treatment failure and disease recurrence. Classical mechanisms, including altered drug uptake and efflux and detoxification by glutathione or metallothioneins, account for only part of this phenotype. Recent work in BCa increasingly points to cisplatin resistance as a multilayered cellular adaptation involving coordinated changes in drug handling, stress responses, and cell-death control. Drawing primarily on studies published between January 2020 and April 2025, while incorporating selected foundational studies from the preceding decade, this review maps cisplatin resistance in BCa within a structured \u201ccell membrane and tumor microenvironment\u2013cytoplasm\u2013nucleus and chromatin\u2013organelles\u201d framework. Particular emphasis is placed on the interaction of epithelial\u2013mesenchymal transition and cancer stem cell programs with stromal and immune signals at the membrane level; on metabolic rewiring, ferroptosis regulation, and stress-activated signaling cascades in the cytoplasm; on reinforced DNA damage response pathways and RNA- or chromatin-directed epigenetic remodeling in the nucleus; and on the resetting of apoptotic, autophagic, and mitophagic thresholds at the organelle level. Across these compartments, recurrent regulatory nodes and signaling axes are outlined, and areas are delineated where mechanisms are supported by convergent\n                    <jats:italic>in vitro<\/jats:italic>\n                    ,\n                    <jats:italic>in vivo<\/jats:italic>\n                    , and clinical evidence versus those that remain primarily exploratory. By viewing cisplatin resistance in BCa as an integrated and dynamic network spanning cellular compartments, this multilayered synthesis aims to refine current mechanistic concepts and to provide a rationale for biomarker development and combination strategies designed to prevent or overcome cisplatin resistance.\n                  <\/jats:p>","DOI":"10.7717\/peerj.21148","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:33:48Z","timestamp":1777019628000},"page":"e21148","source":"Crossref","is-referenced-by-count":2,"title":["Multilayered analysis of cisplatin resistance mechanisms in bladder cancer: from the cell membrane to organelles"],"prefix":"10.7717","volume":"14","author":[{"given":"Longtu","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China"},{"name":"Institute of Urology, Clinical Research Center for Urology in Gansu Province, Key Laboratory of Urological Disease in Gansu Province, Lanzhou University Second Hospital, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China"},{"name":"Institute of Urology, Clinical Research Center for Urology in Gansu Province, Key Laboratory of Urological Disease in Gansu Province, Lanzhou University Second Hospital, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China"},{"name":"Institute of Urology, Clinical Research Center for Urology in Gansu Province, Key Laboratory of Urological Disease in Gansu Province, Lanzhou University Second Hospital, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"You","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China"},{"name":"Institute of Urology, Clinical Research Center for Urology in Gansu Province, Key Laboratory of Urological Disease in Gansu Province, Lanzhou University Second Hospital, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China"},{"name":"Institute of Urology, Clinical Research Center for Urology in Gansu Province, Key Laboratory of Urological Disease in Gansu Province, Lanzhou University Second Hospital, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China"},{"name":"Institute of Urology, Clinical Research Center for Urology in Gansu Province, Key Laboratory of Urological Disease in Gansu Province, Lanzhou University Second Hospital, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidong","family":"Liu","sequence":"additional","affiliation":[{"name":"The Affiliated Taian City Central Hospital of Qingdao University, Taian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China"},{"name":"Institute of Urology, Clinical Research Center for Urology in Gansu Province, Key Laboratory of Urological Disease in Gansu Province, Lanzhou University Second Hospital, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"10.7717\/peerj.21148\/ref-1","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3390\/cancers16071418","article-title":"Cisplatin-resistant urothelial bladder cancer cells undergo metabolic reprogramming beyond the Warburg effect","volume":"16","author":"Afonso","year":"2024","journal-title":"Cancers"},{"key":"10.7717\/peerj.21148\/ref-2","doi-asserted-by":"publisher","first-page":"106652","DOI":"10.1016\/j.biocel.2024.106652","article-title":"MicroRNA-146b-5p\/FDFT1 mediates cisplatin sensitivity in bladder cancer by redirecting cholesterol biosynthesis to the non-sterol branch","volume":"176","author":"Azhar","year":"2024","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"10.7717\/peerj.21148\/ref-3","doi-asserted-by":"publisher","first-page":"e186688","DOI":"10.1172\/JCI186688","article-title":"Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancer","volume":"135","author":"B\u00f6rcs\u00f6k","year":"2025","journal-title":"Journal of Clinical Investigation"},{"key":"10.7717\/peerj.21148\/ref-4","doi-asserted-by":"publisher","first-page":"123228","DOI":"10.1016\/j.lfs.2024.123228","article-title":"Transcription factor PRRX1-activated ANXA6 facilitates EGFR-PKC\u03b1 complex formation and enhances cisplatin sensitivity in bladder cancer","volume":"359","author":"Cao","year":"2024","journal-title":"Life Sciences"},{"key":"10.7717\/peerj.21148\/ref-5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41419-024-07321-1","article-title":"Mechanistic insights into SIRT7 and EZH2 regulation of cisplatin resistance in bladder cancer cells","volume":"15","author":"Cao","year":"2024","journal-title":"Cell Death & Disease"},{"key":"10.7717\/peerj.21148\/ref-6","doi-asserted-by":"publisher","first-page":"111723","DOI":"10.1016\/j.cbi.2025.111723","article-title":"Natural lignan justicidin A-induced mitophagy as a targetable niche in bladder cancer","volume":"421","author":"Chang","year":"2025","journal-title":"Chemico-Biological Interactions"},{"key":"10.7717\/peerj.21148\/ref-7","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.3390\/ijms20174136","article-title":"New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment","volume":"20","author":"Chen","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.7717\/peerj.21148\/ref-8","doi-asserted-by":"publisher","first-page":"e13325","DOI":"10.1111\/cpr.13325","article-title":"Knockdown of ZBTB11 impedes R-loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer","volume":"55","author":"Chen","year":"2022","journal-title":"Cell Proliferation"},{"key":"10.7717\/peerj.21148\/ref-9","doi-asserted-by":"publisher","first-page":"572672","DOI":"10.3389\/fonc.2020.572672","article-title":"Reduction of bladder cancer chemosensitivity induced by the effect of HOXA-AS3 as a ceRNA for miR-455-5p that upregulates Notch1","volume":"10","author":"Chen","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"10.7717\/peerj.21148\/ref-10","doi-asserted-by":"publisher","first-page":"18310","DOI":"10.18632\/aging.203277","article-title":"BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell","volume":"13","author":"Chen","year":"2021","journal-title":"Aging"},{"key":"10.7717\/peerj.21148\/ref-11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.canlet.2021.03.012","article-title":"CDK7 inhibition by THZ1 suppresses cancer stemness in both chemona\u00efve and chemoresistant urothelial carcinoma via the hedgehog signaling pathway","volume":"507","author":"Chow","year":"2021","journal-title":"Cancer Letters"},{"issue":"Suppl 1","key":"10.7717\/peerj.21148\/ref-12","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1182\/blood-2023-190672","article-title":"Protective role of oxaliplatin among platinum-based therapies in the development of therapy-related myeloid neoplasms","volume":"142","author":"Connors","year":"2023","journal-title":"Blood"},{"key":"10.7717\/peerj.21148\/ref-13","doi-asserted-by":"publisher","first-page":"149590","DOI":"10.1016\/j.gene.2025.149590","article-title":"Uncovering citron kinase as a key biomarker for predicting outcomes and therapy efficacy in non-muscle-invasive bladder cancer","volume":"963","author":"Deng","year":"2025","journal-title":"Gene"},{"key":"10.7717\/peerj.21148\/ref-14","doi-asserted-by":"publisher","first-page":"e2408599","DOI":"10.1002\/advs.202408599","article-title":"Enhanced oxidative phosphorylation driven by TACO1 mitochondrial translocation promotes stemness and cisplatin resistance in bladder cancer","volume":"12","author":"Deng","year":"2025","journal-title":"Advanced Science"},{"key":"10.7717\/peerj.21148\/ref-15","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.26355\/eurrev_202210_30042","article-title":"Vitamin D3 sensitizes resistant human bladder cancer cells to cisplatin by regulating Sirtuin 1 gene expression","volume":"26","author":"Di","year":"2022","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"1","key":"10.7717\/peerj.21148\/ref-16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1186\/s12935-021-02363-3","article-title":"Attenuated expression of SNF5 facilitates progression of bladder cancer via STAT3 activation","volume":"21","author":"Ding","year":"2021","journal-title":"Cancer Cell International"},{"issue":"3","key":"10.7717\/peerj.21148\/ref-17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21037\/atm-25-7","article-title":"The 6-methyladenine erasers ALKBH5 and FTO influence chemotherapy efficiency in bladder cancer cell lines","volume":"13","author":"Drigeard\u00a0Desgarnier","year":"2025","journal-title":"Annals of Translational Medicine"},{"issue":"8","key":"10.7717\/peerj.21148\/ref-18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2174\/0109298665403178250806111943","article-title":"Mevalonate metabolic reprogramming drives cisplatin resistance in bladder cancer: mechanisms and therapeutic targeting","volume":"32","author":"Fang","year":"2025","journal-title":"Protein and Peptide Letters"},{"issue":"1","key":"10.7717\/peerj.21148\/ref-19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/1574892816666210907101146","article-title":"Metallodrugs as anticancer chemotherapeutics and diagnostic agents: a critical patent review (2010\u20132020)","volume":"17","author":"Fotopoulou","year":"2022","journal-title":"Recent Patents on Anti-Cancer Drug Discovery"},{"issue":"2","key":"10.7717\/peerj.21148\/ref-20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2174\/157489206777442287","article-title":"Recent developments in the field of anticancer platinum complexes","volume":"1","author":"Galanski","year":"2006","journal-title":"Recent Patents on Anti-Cancer Drug Discovery"},{"key":"10.7717\/peerj.21148\/ref-21","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.freeradbiomed.2023.09.017","article-title":"CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathway","volume":"208","author":"Gao","year":"2023","journal-title":"Free Radical Biology and Medicine"},{"key":"10.7717\/peerj.21148\/ref-22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.trecan.2019.05.011","article-title":"Treatment options and outcomes in nonmetastatic muscle invasive bladder cancer","volume":"5","author":"Ghandour","year":"2019","journal-title":"Trends Cancer"},{"key":"10.7717\/peerj.21148\/ref-23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s42003-024-07284-1","article-title":"SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathway","volume":"8","author":"Gong","year":"2025","journal-title":"Communications Biology"},{"key":"10.7717\/peerj.21148\/ref-24","doi-asserted-by":"publisher","first-page":"eaba0443","DOI":"10.1126\/scisignal.aba0443","article-title":"GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma","volume":"13","author":"Hayashi","year":"2020","journal-title":"Science Signaling"},{"issue":"1","key":"10.7717\/peerj.21148\/ref-25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/cimb47010043","article-title":"Acidic microenvironment enhances cisplatin resistance in bladder cancer via Bcl-2 and XIAP","volume":"47","author":"Hiruma","year":"2025","journal-title":"Current Issues in Molecular Biology"},{"key":"10.7717\/peerj.21148\/ref-26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00018-024-05320-1","article-title":"Nuclear translocation of ISG15 regulated by PPP2R2B inhibits cisplatin resistance of bladder cancer","volume":"81","author":"Huang","year":"2024","journal-title":"Cellular and Molecular Life Science"},{"key":"10.7717\/peerj.21148\/ref-27","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.7150\/ijbs.96671","article-title":"PTBP1-mediated biogenesis of circATIC promotes progression and cisplatin resistance of bladder cancer","volume":"20","author":"Huang","year":"2024","journal-title":"International Journal of Biological Sciences"},{"issue":"9","key":"10.7717\/peerj.21148\/ref-28","doi-asserted-by":"publisher","first-page":"103665","DOI":"10.1016\/j.jpet.2025.103665","article-title":"Transient receptor potential vanilloid type 4 channels mediate bladder cancer cell proliferation, migration, and chemoresistance","volume":"392","author":"Katari","year":"2025","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.7717\/peerj.21148\/ref-29","doi-asserted-by":"publisher","first-page":"101224","DOI":"10.1016\/j.xcrm.2023.101224","article-title":"Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer","volume":"4","author":"Kim","year":"2023","journal-title":"Cell Reports Medicine"},{"key":"10.7717\/peerj.21148\/ref-30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3389\/fcell.2020.00760","article-title":"Epithelial-mesenchymal transition and metabolic switching in cancer: lessons from somatic cell reprogramming","volume":"8","author":"Lai","year":"2020","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.7717\/peerj.21148\/ref-31","doi-asserted-by":"publisher","first-page":"102534","DOI":"10.1016\/j.tranon.2025.102534","article-title":"Dioscin initiates dual roles in bladder cancer progression via miR-195-5p\/FASN\/SLC3A2 axis-mediated cell death mechanisms","volume":"61","author":"Lai","year":"2025","journal-title":"Translational Oncology"},{"key":"10.7717\/peerj.21148\/ref-32","doi-asserted-by":"publisher","first-page":"118032","DOI":"10.1016\/j.biopha.2025.118032","article-title":"Suppression of cisplatin induced ATF3 expression and apoptosis by BK polyomavirus and its encoded microRNA in bladder cancer cells","volume":"186","author":"Li","year":"2025","journal-title":"Biomedicine and Pharmacotherapy"},{"issue":"18","key":"10.7717\/peerj.21148\/ref-33","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.2174\/0118715206304668240729093158","article-title":"Cyclanoline reverses cisplatin resistance in bladder cancer cells by inhibiting the JAK2\/STAT3 pathway","volume":"24","author":"Li","year":"2024","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"key":"10.7717\/peerj.21148\/ref-34","doi-asserted-by":"publisher","first-page":"116903","DOI":"10.1016\/j.bcp.2025.116903","article-title":"N6-methyladenosine-modified RNF220 induces cisplatin resistance and immune escape via regulating PDE10A K48-linked ubiquitination in bladder cancer","volume":"236","author":"Li","year":"2025","journal-title":"Biochemical Pharmacology"},{"issue":"8","key":"10.7717\/peerj.21148\/ref-35","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3390\/ph18081185","article-title":"A COX-2-targeted Platinum(IV) prodrug induces apoptosis and reduces inflammation in bladder cancer models","volume":"18","author":"Li","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.7717\/peerj.21148\/ref-36","doi-asserted-by":"publisher","first-page":"e18473","DOI":"10.1111\/jcmm.18473","article-title":"Unveiling the role of RAC3 in the growth and invasion of cisplatin-resistant bladder cancer cells","volume":"28","author":"Li","year":"2024","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.7717\/peerj.21148\/ref-37","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/tox.24153","article-title":"PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in bladder cancer","volume":"39","author":"Li","year":"2024","journal-title":"Environmental Toxicology"},{"key":"10.7717\/peerj.21148\/ref-38","doi-asserted-by":"publisher","first-page":"954836","DOI":"10.3389\/fimmu.2022.954836","article-title":"FGFBP1 as a potential biomarker predicting bacillus Calmette\u2013Gu\u00e9rin response in bladder cancer","volume":"13","author":"Li","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.7717\/peerj.21148\/ref-39","doi-asserted-by":"publisher","first-page":"9303","DOI":"10.26355\/eurrev_202009_23012","article-title":"Suppression of HAX-1 induced by miR-325 resensitizes bladder cancer cells to cisplatin-induced apoptosis","volume":"24","author":"Li","year":"2020","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.7717\/peerj.21148\/ref-40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13046-025-03487-4","article-title":"Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer","volume":"44","author":"Li","year":"2025","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.7717\/peerj.21148\/ref-41","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1111\/odi.14209","article-title":"Epithelial\u2013mesenchymal transition and cancer stem cells: a route to acquired cisplatin resistance through epigenetics in HNSCC","volume":"29","author":"Lima De\u00a0Oliveira","year":"2023","journal-title":"Oral Diseases"},{"key":"10.7717\/peerj.21148\/ref-42","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3390\/jcm11082208","article-title":"HUS1 as a potential therapeutic target in urothelial cancer","volume":"11","author":"Lindner","year":"2022","journal-title":"Journal of Clinical Medicine"},{"key":"10.7717\/peerj.21148\/ref-43","doi-asserted-by":"publisher","first-page":"e70595","DOI":"10.1096\/fj.202500423R","article-title":"AP1M2 drives gemcitabine-cisplatin chemoresistance by enhancing RAD54B-associated DNA repair in bladder cancer","volume":"39","author":"Liu","year":"2025","journal-title":"FASEB Journal"},{"key":"10.7717\/peerj.21148\/ref-44","doi-asserted-by":"publisher","first-page":"120502","DOI":"10.1016\/j.jep.2025.120502","article-title":"Targeting GRB2-Akt-SREBP1 signaling axis by saponins from Paris polyphylla Smith var. yunnanensis (Franch.) Hand.-Mazz to overcome cisplatin resistance in bladder cancer","volume":"354","author":"Liu","year":"2025","journal-title":"Journal of Ethnopharmacology"},{"key":"10.7717\/peerj.21148\/ref-45","doi-asserted-by":"publisher","first-page":"101962","DOI":"10.1016\/j.tranon.2024.101962","article-title":"A novel LINC02321 promotes cell proliferation and decreases cisplatin sensitivity in bladder cancer by regulating RUVBL2","volume":"45","author":"Lu","year":"2024","journal-title":"Translational Oncology"},{"key":"10.7717\/peerj.21148\/ref-46","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/cancers14071717","article-title":"FOXC1 binds enhancers and promotes cisplatin resistance in bladder cancer","volume":"14","author":"Lu","year":"2022","journal-title":"Cancer"},{"key":"10.7717\/peerj.21148\/ref-47","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/abbs\/gmab023","article-title":"Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p\/ABCB1 axis","volume":"53","author":"Luo","year":"2021","journal-title":"Acta Biochimica et Biophysica Sinica"},{"issue":"1","key":"10.7717\/peerj.21148\/ref-48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12920-025-02146-z","article-title":"LIMA1 inhibits cisplatin resistance and malignant biological behavior of bladder cancer cells by suppressing the Wnt\/\u03b2-catenin pathway","volume":"18","author":"Lv","year":"2025","journal-title":"BMC Medical Genomics"},{"key":"10.7717\/peerj.21148\/ref-49","doi-asserted-by":"publisher","first-page":"111164","DOI":"10.1016\/j.cellsig.2024.111164","article-title":"CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway","volume":"119","author":"Lyu","year":"2024","journal-title":"Cellular Signalling"},{"key":"10.7717\/peerj.21148\/ref-50","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/pharmaceutics14061303","article-title":"Metabolic reprogramming in cancer cells: emerging molecular mechanisms and novel therapeutic approaches","volume":"14","author":"Navarro","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.7717\/peerj.21148\/ref-51","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.7150\/ijbs.109973","article-title":"Novel glycoprotein SBSPON suppressed bladder cancer through the AKT signal pathway by inhibiting HSPA5 membrane translocation","volume":"21","author":"Ni","year":"2025","journal-title":"International Journal of Biological Sciences"},{"key":"10.7717\/peerj.21148\/ref-52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12885-020-07717-0","article-title":"EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer","volume":"21","author":"Okamura","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.7717\/peerj.21148\/ref-53","doi-asserted-by":"publisher","first-page":"530","DOI":"10.30574\/wjarr.2024.23.1.2038","article-title":"A review of metabolic reprogramming in cancer cells: mechanisms and therapeutic targets","volume":"23","author":"Otakhor","year":"2024","journal-title":"World Journal of Advanced Research and Reviews"},{"issue":"6","key":"10.7717\/peerj.21148\/ref-54","doi-asserted-by":"publisher","first-page":"e24452","DOI":"10.1002\/jcla.24452","article-title":"Piperlongumine increases the sensitivity of bladder cancer to cisplatin by mitochondrial ROS","volume":"36","author":"Pan","year":"2022","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"10.7717\/peerj.21148\/ref-55","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/1878-0261.13659","article-title":"Glutathione S-transferase omega class 1 (GSTO1)-associated large extracellular vesicles are involved in tumor-associated macrophage-mediated cisplatin resistance in bladder cancer","volume":"18","author":"Pan","year":"2024","journal-title":"Molecular Oncology"},{"key":"10.7717\/peerj.21148\/ref-56","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.eururo.2022.08.012","article-title":"Outpatient photodynamic diagnosis\u2013guided laser destruction of bladder tumors is as good as conventional inpatient photodynamic diagnosis\u2013guided transurethral tumor resection in patients with recurrent intermediate-risk low-grade Ta bladder tumors. A prospective randomized noninferiority clinical trial","volume":"83","author":"Pedersen","year":"2023","journal-title":"European Urology"},{"issue":"5","key":"10.7717\/peerj.21148\/ref-57","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3892\/ijmm.2021.5037","article-title":"SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO\/STAT3 axis","volume":"48","author":"Qin","year":"2021","journal-title":"International Journal of Molecular Medicine"},{"key":"10.7717\/peerj.21148\/ref-58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12943-022-01517-9","article-title":"Targeting HNRNPU to overcome cisplatin resistance in bladder cancer","volume":"21","author":"Shi","year":"2022","journal-title":"Molecular Cancer"},{"key":"10.7717\/peerj.21148\/ref-59","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/1541-7786.MCR-19-1200","article-title":"Differential effects of clinically relevant N-versus C-terminal truncating CDKN1A mutations on cisplatin sensitivity in bladder cancer","volume":"19","author":"Sikder","year":"2021","journal-title":"Molecular Cancer Research"},{"key":"10.7717\/peerj.21148\/ref-60","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.7150\/ijbs.103522","article-title":"IGF2BP3 promotes the proliferation and cisplatin resistance of bladder cancer by enhancing the mRNA stability of CDK6 in an m6A dependent manner","volume":"21","author":"Song","year":"2025","journal-title":"International Journal of Biological Sciences"},{"key":"10.7717\/peerj.21148\/ref-61","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1038\/s41598-023-36774-1","article-title":"Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer","volume":"13","author":"Steele","year":"2023","journal-title":"Scientific Reports"},{"key":"10.7717\/peerj.21148\/ref-62","doi-asserted-by":"publisher","first-page":"e13404","DOI":"10.1111\/cpr.13404","article-title":"YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer","volume":"56","author":"Su","year":"2023","journal-title":"Cell Proliferation"},{"issue":"1","key":"10.7717\/peerj.21148\/ref-63","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/cancers16010125","article-title":"SIRT1 promotes cisplatin resistance in bladder cancer via Beclin1 deacetylation-mediated autophagy","volume":"16","author":"Sun","year":"2024","journal-title":"Cancer"},{"key":"10.7717\/peerj.21148\/ref-64","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.7717\/peerj.21148\/ref-65","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.tranon.2025.102537","article-title":"A CEBPB\/TYMP\/GDF15 signaling axis mediates tumor growth and cisplatin resistance in bladder cancer","volume":"61","author":"Tian","year":"2025","journal-title":"Translational Oncology"},{"key":"10.7717\/peerj.21148\/ref-66","doi-asserted-by":"publisher","first-page":"139777","DOI":"10.1016\/j.ijbiomac.2025.139777","article-title":"The MCM6-c-Myc positive feedback loop mediates bladder cancer progression and cisplatin resistance","volume":"296","author":"Wang","year":"2025","journal-title":"International Journal of Biological Macromolecules"},{"issue":"1","key":"10.7717\/peerj.21148\/ref-67","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13046-023-02932-6","article-title":"EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance","volume":"43","author":"Wei","year":"2024","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.7717\/peerj.21148\/ref-68","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1158\/0008-5472.CAN-21-1518","article-title":"Circ0008399 interaction with WTAP promotes assembly and activity of the m6A methyltransferase complex and promotes cisplatin resistance in bladder cancer","volume":"81","author":"Wei","year":"2021","journal-title":"Cancer Research"},{"issue":"9","key":"10.7717\/peerj.21148\/ref-69","doi-asserted-by":"publisher","first-page":"e70042","DOI":"10.1002\/kjm2.70042","article-title":"LRP8 regulates lipid metabolism to stimulate malignant progression and cisplatin resistance in bladder cancer","volume":"41","author":"Wu","year":"2025","journal-title":"The Kaohsiung Journal of Medical Sciences"},{"issue":"1","key":"10.7717\/peerj.21148\/ref-70","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12967-025-06547-7","article-title":"SRSF1-mediated alternative splicing regulates bladder cancer progression and cisplatin sensitivity through HIF1A\/BNIP3\/mitophagy axis","volume":"23","author":"Wu","year":"2025","journal-title":"Journal of Translational Medicine"},{"issue":"17","key":"10.7717\/peerj.21148\/ref-71","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.scib.2021.01.027","article-title":"MAFG-AS1\/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis","volume":"66","author":"Xiang","year":"2021","journal-title":"Science Bulletin"},{"key":"10.7717\/peerj.21148\/ref-72","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","article-title":"NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer","volume":"83","author":"Xie","year":"2023","journal-title":"Cancer Research"},{"key":"10.7717\/peerj.21148\/ref-73","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.7150\/jca.58049","article-title":"ADNP prompts the cisplatin-resistance of bladder cancer via TGF-\u03b2-mediated epithelial-mesenchymal transition (EMT) pathway","volume":"12","author":"Xie","year":"2021","journal-title":"Journal of Cancer"},{"key":"10.7717\/peerj.21148\/ref-74","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.3390\/cancers14194809","article-title":"TFAP2C knockdown sensitizes bladder cancer cells to cisplatin treatment via regulation of EGFR and NF-\u03baB","volume":"14","author":"Xing","year":"2022","journal-title":"Cancer"},{"key":"10.7717\/peerj.21148\/ref-75","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s11658-024-00543-3","article-title":"N6-methyladenosine-modified circ_104797 sustains cisplatin resistance in bladder cancer through acting as RNA sponges","volume":"29","author":"Xu","year":"2024","journal-title":"Cellular & Molecular Biology Letters"},{"key":"10.7717\/peerj.21148\/ref-76","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ajpath.2022.12.005","article-title":"Cancer antigen 125 expression enhances the gemcitabine\/cisplatin-resistant tumor microenvironment in bladder cancer","volume":"193","author":"Yamashita","year":"2023","journal-title":"American Journal of Pathology"},{"issue":"1","key":"10.7717\/peerj.21148\/ref-77","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12935-024-03570-4","article-title":"IMP2 drives chemoresistance by repressing cisplatin-induced apoptosis and ferroptosis via activation of IPO4 and SLC7A11 under hypoxia in bladder cancer","volume":"24","author":"Yan","year":"2024","journal-title":"Cancer Cell International"},{"key":"10.7717\/peerj.21148\/ref-78","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41419-023-06050-1","article-title":"Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death & Disease"},{"key":"10.7717\/peerj.21148\/ref-79","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.7717\/peerj.21148\/ref-80","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.7150\/ijbs.86719","article-title":"METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway","volume":"20","author":"Yu","year":"2024","journal-title":"International Journal of Biological Sciences"},{"issue":"1","key":"10.7717\/peerj.21148\/ref-81","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Molecular Cancer"},{"key":"10.7717\/peerj.21148\/ref-82","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.1007\/s00210-024-03061-3","article-title":"PAX2 mediated upregulation of ESPL1 contributes to cisplatin resistance in bladder cancer through activating the JAK2\/STAT3 pathway","volume":"397","author":"Zhang","year":"2024","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"key":"10.7717\/peerj.21148\/ref-83","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.canlet.2012.02.010","article-title":"Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer","volume":"322","author":"Zhang","year":"2012","journal-title":"Cancer Letters"},{"issue":"1","key":"10.7717\/peerj.21148\/ref-84","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-021-01360-4","article-title":"CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutS\u03b1\/ATM-p73 axis in bladder cancer","volume":"20","author":"Zhang","year":"2021","journal-title":"Molecular Cancer"},{"key":"10.7717\/peerj.21148\/ref-85","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3892\/or.2022.8453","article-title":"Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis","volume":"49","author":"Zhao","year":"2023","journal-title":"Oncology Reports"},{"key":"10.7717\/peerj.21148\/ref-86","doi-asserted-by":"publisher","first-page":"1585727","DOI":"10.3389\/fimmu.2025.1585727","article-title":"Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancer","volume":"16","author":"Zhao","year":"2025","journal-title":"Frontiers in Immunology"},{"key":"10.7717\/peerj.21148\/ref-87","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/15384101.2024.2353554","article-title":"Pseudogene OCT4-pg5 upregulates OCT4B expression to promote bladder cancer progression by competing with miR-145-5p","volume":"23","author":"Zhou","year":"2024","journal-title":"Cell Cycle"},{"key":"10.7717\/peerj.21148\/ref-88","doi-asserted-by":"publisher","first-page":"6905","DOI":"10.3390\/ijms24086905","article-title":"YTHDF1 promotes bladder cancer cell proliferation via the METTL3\/YTHDF1-RPN2-PI3K\/AKT\/mTOR axis","volume":"24","author":"Zhu","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.7717\/peerj.21148\/ref-89","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/0008-5472.CAN-22-2213","article-title":"Cancer-associated fibroblast-derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance","volume":"83","author":"Zhuang","year":"2023","journal-title":"Cancer Research"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/21148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21148.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21148.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21148.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:33:50Z","timestamp":1777019630000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/21148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":89,"alternative-id":["10.7717\/peerj.21148"],"URL":"https:\/\/doi.org\/10.7717\/peerj.21148","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"e21148"}}